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1477Stent implantation has become a routine procedure, resulting
in greater freedom from angina than medical therapy does (1),
and stents are used in about 90% of all percutaneous inter-
ventions, with about 528,000 procedures per year in the United
States and 854,000 in Europe (2,3). Computed tomography
angiography (CTA) is not recommended in patients with
coronary stents because of high rates of nondiagnostic stents
(4), mainly due to artifacts resulting from the metallic material
of stent struts and fast coronary artery motion. High and
irregular heart rates enhance artifacts caused by metal stents
(5). Magnetic resonance angiography is hampered by signal
loss in the stent, and patency can only be assessed distal to
stents (6).
See page 1486
The increasing use of stents in small vessels (7) makes it
even more difﬁcult to reliably depict coronary in-stent
restenosis (ISR) by CTA (8). Strategies to improve CT
can be classiﬁed into those improving spatial and temporal
resolution (9), and those providing additional functional
information (10). State-of-the-art CT can combine volu-
metric coverage and reduced radiation for coronary angiog-
raphy (9) with myocardial computed tomography perfusion
(CTP) in a single examination (10).
We conducted a prospective study of CTA and CTP
using 320 detector rows for identifying coronary ISR or any
coronary artery disease (CAD).
Methods
Study design. The CARS-320 (Coronary Artery Stent
Evaluation with 320-Row Computed Tomography) study is
a prospective study for detecting coronary ISR using quan-
titative coronary angiography (QCA) as the reference stan-
dard. In this intention-to-diagnose study, all patients and
stents were included regardless of type, size, or number of
stents and duration since implantation, even if a study or
a vessel segment was nondiagnostic, to avoid overestimating
diagnostic accuracy (11). The 25 criteria of the Standards for
Reporting of Diagnostic Accuracy statement (12) are given
in Online Figure 1.
CT was performed 14 days before conventional coro-
nary angiography (CCA) to avoid differential veriﬁcation
and disease progression bias (13). The study protocol was
approved by the Charité ethics board (EA1/133/08) and the
Federal Ofﬁce for Radiation Protection (BfS Z5-22462/
2-2008-057).
Study population. Consecutive patients with clinically
suspected coronary ISR referred to Charité for CCA were
included if they were at least 40 years and had sinus rhythm.
Exclusion criteria are listed in Figure 1. Patients were
enrolled between April 2, 2009, and November 23, 2011,
and all gave written informed consent.
Preparation for CT. Seventy-six patients were on chronic
oral beta-blocker medications (84%), and 73 receivedadditional oral beta-blockade
medications (71  44 mg ate-
nolol, Tenormin, AstraZeneca,
Wedel, Germany) 1 h before
CTA. Immediately before CTA,
intravenous beta-blockers (mean:
44  103 mg esmolol, Brevibloc,
Baxter, Unterschleissheim, Ger-
many) were given in 16 patients
(18%) with heart rates above 60
beats/min and all patients re-
ceived 0.8 mg glycerol trinitrate
sublingually (NitrolingualNSpray,
Pohl-Boskamp, Hohenlockstedt,
Germany) (14).
Coronary CTA andCTP. Data
were acquired on 320-row CT (0.5-mm detector colli-
mation and 350-ms gantry rotation time; Aquilion ONE,
Toshiba Medical Systems, Otawara, Japan) as recently
described (9). Noncontrast CT was acquired using
prospective triggering to assess coronary calcium (120 kV,
150 mA) and deﬁne the anatomical range for subsequent
CTA/CTP (15). For CTA and CTP, a nonionic contrast
agent (50 to 70 ml of iomeprol, Iomeron 400, 400 mg
iodine/ml, Bracco Imaging, Milan, Italy) was injected into
an antecubital vein of the right arm (except for 2 patients
each in whom injection was done at the back of the hand
and forearm). The amount and ﬂow of contrast agent was
adjusted to body weight (16). For CTA, we used
prospective triggering with scanner settings of 120 kV
and tube currents adjusted to the body mass index, as
described (16).
CTP was performed with a delay of at least 20 min after
nitroglycerin as described (16); another contrast agent
injection followed 4 min after the beginning of intravenous
infusion of adenosine in the antecubital fossa of the left
arm (140 mg/kg/min; Adenosin Life Medical, Car-
inopharm GmbH, Gronau/Leine, Germany), except for 4
and 2 patients in whom adenosine infusion was done at the
back of the hand and forearm, respectively. Adenosine
infusion was continued until completion of contrast agent
injection. For CTP, we used the target mode with scanner
settings of 120 kV and tube currents adjusted to body mass
index (16).
CTA and CTP were initiated when bolus tracking
detected an absolute increase of 200 Hounsﬁeld units in the
descending aorta following identical amounts of contrast
agent (16). Using a conversion factor of 0.014 mSv/mGy cm
(17), the effective dose was estimated for CT.
CTA and CTP reconstruction and evaluation. CT data
were reconstructed with validated beam hardening correc-
tion (18), the kernels FC3/CTA and FC5/stent, an
imaging matrix of 512  512 pixels, and 0.5-mm slice
thickness on an 18-cm ﬁeld-of-view using automated best-
phase reconstructions and additional 5% intervals. A
0.25-mm slice increment improved rendering. Adaptive
Figure 1
Flow Diagram of Patient Recruitment and Examination According to the Standards for Reporting of
Diagnostic Accuracy Statement
*No patient had to be excluded for the following exclusion criteria: inability to hold breath for 10 s; body weight >300 kg; pregnancy; therapy with dipyridamole; second- or third-
degree atrioventricular block; systolic hypotension; and guardianship at the time of the study. xReasons given by those who declined to participate (n ¼ 27): 20 gave no reason;
given, 4 were afraid of adenosine application; 1 was not available on the ward for informed consent; 1 had orthopnea; 1 did not speak German or English. The 128 eligible
patients who could not be included in comparison to the 91 patients included were more often women (34 vs. 20%; p ¼ 0.02) and slightly older (66.3  9.7 years; p ¼ 0.08) but
had the same prevalence of in-stent restenosis (ISR) (18 vs. 19%; p ¼ 0.85). yAnticoagulation was initiated, but computed tomography perfusion (CTP) was not performed.
Computed coronary angiography (CCA) in this patient showed ISR type IV (occlusion) in the mid–left anterior descending artery that was also seen on computed tomography
angiography (CTA). zThis includes 1 patient in whom CTP could not be performed because of severe angina pectoris during adenosine infusion but before CTP. In this patient,
3-vessel disease without ISR was seen on both CTA and CCA. CT ¼ computed tomography; QCA ¼ quantitative coronary angiography.
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1478multisegment reconstruction was used in patients with
heart rates above 65 beats/min (CTA: 4 patients; CTP:
60 patients) and half-scan reconstruction in patients with
lower heart rates.
Stenosis assessment was performed with the workstation’s
(Vitrea fX, Vital Images, Plymouth, Minnesota) coronary
artery CT protocol using automated vessel probing. ISR and
stenoses in native vessels were detected visually on original
slices, orthogonal planes, cross sections of the stent, andcurved multiplanar reformations. At least 20% of visual
diameter reductions were quantiﬁed on images orthogonal to
the vessel (9). CTP was analyzed visually based on determi-
nation of the arterial input function (19) on a dedicated
myocardial perfusion workstation (version 4.71GR001
W.I.P, Toshiba Medical Systems, Nasu, Japan) (16). Con-
tiguous short- and long-axis analysis was performed visually
in 3-mm intervals using 8-mm slice thickness to identify
perfusion defects during rest and stress. In addition, 2
Table 1
Characteristics of the 91 Patients With Suspected
ISR Who Completed the Study
Age, yrs 64  10
Male 73 (80)
Hyperlipidemia 76 (84)
Arterial hypertension 76 (84)
Diabetes mellitus 25 (27)
Height, m 1.72  0.08
Weight, kg 82.1  12.0
Body mass index* 27.7  3.8
Waist circumference, m 1.01  0.10
Creatinine, mg/dl 0.94  0.17
eGFR, ml/min/1.73 m2 92.4  25.2
Clinical presentation (27)
Typical angina 15 (16)
Atypical angina 37 (41)
Nonspeciﬁc chest pain 31 (34)
No chest painy 8 (9)
Stent information
On the patient level (n ¼ 91)
No. of stents per patient 2.5  1.8
Minimum and maximum no.
of stents per patient
1 and 10
Time since ﬁrst stent,
months
41  47 (min: 0.7; max: 190)
Time since last stent,
months
31  42 (min: 0.6; max: 190)
On the stent level (n ¼ 221)
Diameter, mm 3.0  0.5
Stent diameter categories
<3.0 mm 85 (38)
¼ 3.0 mm 100 (45)
>3.0 mm 39 (17)
Length, mm 17.1  6.0
Location of stents in the
main vessels
Left anterior descending
coronary artery
92 (41)
Left circumﬂex coronary
artery
49 (22)
Left main coronary artery 2 (1)
Intermediate branch 2 (1)
Right coronary artery 79 (35)
Prior myocardial infarction 43 (47)
Current cigarette smoking 19 (21)
Continued in the next column
Table 1 Continued
Medication
Beta blockers 76 (84)
ACE inhibitors 55 (60)
Statins 81 (89)
ASA 84 (92)
At least 1 stress test prior to
coronary angiography
41 (45)
Stress echocardiography 9 (10)
Positive 4 (4)
Negative 5 (6)
Exercise ECG 16 (18)
Positive 9 (10)
Negative 7 (8)
Duke score (28) 0.28  7.7
SPECT 23 (26)
Positive 18 (20)
Negative 5 (6)
Stress MRI 10 (11)
Positive 6 (7)
Negative 4 (4)
FFR 8 (9)
Positive (<0.80) (29) 3 (3)
Negative 5 (6)
Heart rate during CTA, beats/min 53.3  7.1 (median: 52.4, range 39–80)
Heart rate during CTP, beats/min 68.1  10.6 (median: 66.3, range 42–96)
Findings on coronary angiographyz
On the patient level, n ¼ 91
No ISR 74 (81)
ISR 17 (19)
1-vessel 16 (18)
2-vessel 1 (1)
3-vessel 0 (0)
On the stent level, n ¼ 224
No ISR 206 (92)
ISR 18 (8)
<3.0-mm diameter stent 7 (39)
¼ 3.0-mm diameter stent 8 (44)
>3.0-mm diameter stent 3 (17)
Percentage of diameter
stenosisx
66  16
Values are mean  SD or n (%) unless otherwise indicated. *Calculated as the weight in kilograms
divided by the square of the height in meters. yAmong the 8 patients (9%) without chest pain
indicated for coronary angiography, 4 were scheduled for 6- or 12-month follow-up examination
after intervention, 1 had positive ischemia testing, and 3 had remaining coronary stenosis of at
least 50% in a nonstented vessel. zBased on assessment of all 17 coronary segments according to
the American Heart Association classiﬁcation (22) (regardless of the size of reference vessel
diameters). xAmong the 18 ISR, 2 stents were completely occluded.
ACE ¼ angiotensin-converting enzyme; ASA ¼ acetylsalicylic acid; CTA ¼ computed tomography
angiography; CTP ¼ computed tomography perfusion; ECG ¼ electrocardiography; eGFR ¼ esti-
mated glomerular ﬁltration rate; FFR ¼ fractional ﬂow reserve; ISR ¼ in-stent restenosis;
MRI ¼ magnetic resonance imaging; SPECT ¼ single-photon emission computed tomography.
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1479semiquantitative parameters, transmural perfusion ratio
(<0.99) (20) and myocardial attenuation, were analyzed (16).
Conventional coronary angiography. CCA was per-
formed using the transfemoral Judkins approach and stan-
dard techniques after right and left intracoronary
administration of 100 to 150 mg isosorbide dinitrate. Radi-
ation exposure was estimated using a conversion factor of
0.22 cGy  cm2 (21). The decision to perform interventions
was based on clinical judgment alone because intervention-
alists were blinded to CT.
Analysis of imaging tests. All 16 coronary artery segments
of the American Heart Association classiﬁcation (22)including the intermediate branch (segment 17, if present)
were analyzed for detection of 50% (obstructive) diameter
stenosis, independent of reference vessel size, in CTA and
QCA. All 17 myocardial segments of the American Heart
Association nomenclature (23) were evaluated by CTP (16).
If a coronary stent was nondiagnostic on CTA, ﬁxed
perfusion defects and reversible ischemia on CTP in the
corresponding myocardial territory were considered positive
for combined CTA/CTP. CTA and CTP were processed
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1480and evaluated separately by 2 independent readers (E.Z. and
A.K. for CTA; M.R. and F.S. for CTP) blinded to the
results of the other CT method, CCA, and clinical infor-
mation. To ensure correct intermodality evaluation of
coronary segments and assignment of myocardial territories
to coronary arteries, a ﬁfth reader not involved in reading
CT and QCA (M.D.) adjudicated all coronary lesions and
myocardial perfusion defects for comparison with CCA.
The adjudication was done separately for detection of ISR
and “any CAD” (including ISR and stenoses in native
vessels). The independent adjudicator was unblinded to the
QCA results, which were used in combination with CTA/
CTP for intermodality adjudication. Unblinding was
necessary to ensure comparison of identical coronary lesions.
The adjudicator also ensured, by a parallel assessment of
CTA and CTP, that the segmental perfusion assessment
(23) documented by the CTP readers corresponded to
coronary ISR or stenoses in native vessels, that is, using
a conservative adjudication by including any coherent
perfusion deﬁcit seen on CTP as an indicator for an ISR if
a nondiagnostic stent was present in the coronary artery
supplying this myocardial territory. In case of stents with
diagnostic image quality on CTA, the CTP reading was not
used to inﬂuence the combined CTA/CTP assessment. For
any CAD, the CTP was used only when a vessel was
nondiagnostic on CTA.
QCA (Axiom Artis BC, Siemens, Erlangen, Germany)
was performed and interpreted independently by another
reader (M.L.), who was unaware of CT results and clinical
information. At least 2 orthogonal projections were evalu-
ated; percentage of diameter stenosis was measured in the
projection showing the highest degree of narrowing.
Statistical analysis. We estimated that 90 patients were
required to conﬁrm that the diagnostic accuracy of CTA/
CTP for coronary ISR was >75% in an exact 2-sided
binomial test with signiﬁcance at 0.05, assuming a true
per-patient accuracy of 87% with a power of 80% (nQuery
Advisor 7.0, Statistical Solutions, Cork, Ireland). The
secondary objective was to analyze the diagnostic accuracy of
CTA/CTP for coronary stenosis in any vessel (any CAD).
McNemar test and Student paired t test were used as
appropriate for categorical and continuous variables.
Generalized estimating equations were used to adjust for
clustering of stents within patients (24). All data are reported
as mean  SD (normally distributed data), medians (data
not normally distributed), or proportions with 95% conﬁ-
dence intervals (CI). For unclustered data (per-patient
analysis), CI for proportions were obtained using the exact
binomial distribution (25). Correlated receiver-operating
characteristic (ROC) curves were compared using the
approach described by DeLong et al. (26). The ROC curves
quantify the readers’ conﬁdence: deﬁnitely no stenosis; most
likely no stenosis; possibly no stenosis; probably no stenosis;
unclear; probably stenotic; possibly stenotic; most likely
stenotic; and deﬁnitely stenotic. In both ROC analyses,
nondiagnostic results were censored as deﬁnitely stenotic.Statistical analyses were conducted using SPSS (version 18.0,
SPSS Inc., Chicago, Illinois) and SAS (version 8.0, SAS
Institute Inc., Cary, North Carolina). CI and p values for
clustered data were calculated using proc genmod in SAS.
Results
The ﬂow of patients is shown in Figure 1. No adverse events
occurred after CTA or CCA. Two patients did not undergo
CTP: 1 because of pulmonary embolism seen on CTA;
another because of severe angina pectoris during adenosine
infusion. The second patient was considered nondiagnostic
by CTP (11). Our ﬁnal cohort included 91 patients (Fig. 1).
Patient characteristics. Patient characteristics are given in
Table 1 (27–29). The average number of stents per patient
was 2.5  1.8 with a median of 2 and a maximum of 10
(Table 1). Most stents were located in the proximal (30,
13%), mid–left anterior descending (37, 17%), or mid–right
coronary (36, 16%) arteries. Nineteen percent (17) had
obstructive coronary ISR by QCA. In addition, QCA
showed obstructive stenosis of nonstented segments in 65%
(n ¼ 59), with 12% (11) also having ISR. About one-half
(48) were over 65 years of age, and 79% (72) had a body
mass index 25. Within 1 month, 10 patients underwent
percutaneous ISR revascularization, and 1 patient with an
ISR was surgically revascularized.
Study ﬂow and further characteristics. The median
interval between CT and CCA was 3 h 35 min (mean: 17 h
7 min; range 77 min to 12 days 23 h 42 min). Seventy
patients (77%) had CT and CCA on the same day. The
median CTA/CTP acquisition time was 0.41/0.86 s, using
a median contrast-medium volume of 120 ml (range 100 to
140 ml; CCA [diagnostic part]: median: 56 ml; range 20 to
130 ml; p < 0.001).
Creatinine and radiation exposure. On creatinine follow-
up 24 to 48 h after CCA, 3 patients showed an increase of
>25% but below 0.5 mg/dl; 2 of them had same-day CT
and CCA, and in 1, the elapsed time was 2 days. Creatinine
normalized on further follow-up in all 3. There was no
signiﬁcant correlation of time between CT and CCA with
the change in creatinine. The effective radiation dose of
CTA/CTP was signiﬁcantly lower than that of CCA
(Fig. 2).
Diagnostic performance. Table 2 summarizes the diag-
nostic performance of CTA and CTA/CTP for ISR. The
primary null hypothesis was rejected, with an observed
per-patient diagnostic accuracy of CTA/CTP for ISR of
87% (p ¼ 0.01; exact binomial test). This diagnostic accu-
racy was signiﬁcantly higher than that of CTA alone (71%;
p < 0.001), whereas the rate of nondiagnostic examinations
was signiﬁcantly reduced (p < 0.001) (Table 2). In the
per-stent analysis, diagnostic accuracy and nondiagnostic
rate were also signiﬁcantly improved by the addition of CTP
(p < 0.001) (Table 2). The per-patient sensitivity and
speciﬁcity for ISR for combined CTA/CTP were 82%
and 88%, respectively, versus 59% (p ¼ 0.13) and 74%
Figure 2 Comparison of Radiation Exposure for CTA, CTP, CTA/CTP, and CCA
The effective radiation dose for CTA (3.0  1.8 mSv) was signiﬁcantly lower than for CCA (9.5  5.1 mSv; excluding revascularization; p < 0.05). CTA also had a signiﬁcantly
lower effective radiation dose than CTP did (4.9  1.9 mSv; p < 0.05). CTA/CTP resulted in a signiﬁcantly lower radiation dose (7.9  2.8 mSv) than CCA did (p ¼ 0.005).
Abbreviations as in Figure 1.
Table 2 Performance of CTA, CTP, and Combined CTA/CTP for the Detection of Coronary ISR
CTA CTP Combined CTA/CTP
QCA as the Reference Standard
Per-patient analysis
Diagnostic accuracy 65/91 (71 [61–80]) 62/91 (68 [58–78]) 79/91 (87 [78–93])*
Nondiagnostic rate 20/91 (22 [14–32]) 1/91 (1 [0–6]) 0/91 (0 [0–4])*
Sensitivity 10/17 (59 [33–82]) 11/17 (65 [38–86]) 14/17 (82 [57–96])
Speciﬁcity 55/74 (74 [63–84]) 51/74 (69 [57–79]) 65/74 (88 [78–94])*
Negative predictive value 55/58 (95 [86–99]) 51/57 (90 [79–96]) 65/68 (96 [88–99])
Positive predictive value 10/13 (77 [46–95]) 11/33 (33 [18–52]) 14/23 (61 [39–80])
Per-stent analysis
Diagnostic accuracy 171/224 (76 [70–82]) 151/224 (67 [61–74]) 199/224 (89 [84–93])*
Nondiagnostic rate 45/224 (20 [15–26]) 3/224 (1 [0–4]) 0/224 (0 [0–2])*
Sensitivity 10/18 (56 [31–78]) 12/18 (67 [41–87]) 14/18 (78 [52–94])
Speciﬁcity 161/206 (78 [72–84]) 139/206 (68 [61–74]) 185/206 (90 [85–94])*
Negative predictive value 161/165 (98 [94–99]) 139/145 (96 [91–99]) 185/189 (98 [95–99])
Positive predictive value 10/14 (71 [42–92]) 12/76 (16 [8–26]) 14/35 (40 [24–58])
Coronary Revascularization as the Reference Standard
Per-patient analysis
Diagnostic accuracy 60/91 (66 [55–76]) 60/91 (66 [55–76]) 72/91 (79 [69–87])*
Nondiagnostic rate 20/91 (22 [14–32]) 1/91 (1 [0–6]) 0/91 (0 [0–4])*
Sensitivity 6/11 (55 [23–83]) 7/11 (64 [31–89]) 8/11 (73 [39–94])
Speciﬁcity 55/80 (69 [57–79]) 53/80 (66 [55–76]) 65/80 (81 [71–89])*
Negative predictive value 55/58 (95 [86–99]) 53/57 (93 [83–98]) 65/68 (96 [88–99])
Positive predictive value 6/13 (46 [19–75]) 7/33 (21 [9–39]) 8/23 (35 [16–57])
Per-stent analysis
Diagnostic accuracy 168/224 (75 [69–81]) 148/224 (66 [60–72]) 200/224 (89 [85–93])*
Nondiagnostic rate 45/224 (20 [15–26]) 3/224 (1 [0–4]) 0/224 (0 [0–2])*
Sensitivity 6/11 (55 [23–83]) 7/11 (64 [31–89]) 8/11 (73 [39–94])
Speciﬁcity 162/213 (76 [70–82]) 141/213 (66 [59–73]) 192/213 (90 [85–94])*
Negative predictive value 162/165 (98 [95–100]) 141/145 (97 [93–99]) 192/195 (99 [96–100])
Positive predictive value 6/14 (43 [18–71]) 7/76 (9 [4–18]) 8/29 (28 [13–47])
Values are n/N (% [95% CI]). Results are provided on the per-patient and -stent level using the following reference standards: 1) QCA for detection of 50% diameter ISR; and 2) subsequent coronary
revascularization of ISR (within 1 month). Using QCA as the reference, diagnostic accuracy (p < 0.001), speciﬁcity (p ¼ 0.004), and nondiagnostic rate (p < 0.001) were signiﬁcantly improved with CTA/CTP
on the per-patient level of analysis. Diagnostic accuracy (p < 0.001), speciﬁcity (p < 0.001), and nondiagnostic rate (p < 0.001) were also signiﬁcantly improved with the combination of CTA and CTP on the
per-stent level of analysis. Similar results were found for coronary revascularization. 95% CI were estimated as described for unclustered data on the per-patient level (25) and clustered data (stent level) as
described (24). *Signiﬁcant difference (p < 0.05) in the comparison of CTA with combined CTA/CTP. The p values were obtained using the sign test.
CI ¼ conﬁdence interval(s); QCA ¼ quantitative coronary angiography; other abbreviations as in Table 1.
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Table 3
Performance of CTA and Combined CTA/CTP for the
Detection of Any Coronary Artery Stenosis
CTA Combined CTA/CTP
QCA as the Reference Standard
Per-patient analysis
Diagnostic accuracy 74/91 (81 [72–89]) 78/91 (86 [77–92])
Nondiagnostic rate 6/91 (7 [3–14]) 0/91 (0 [0–4])*
Sensitivity 59/65 (91 [81–97]) 61/65 (94 [85–98])
Speciﬁcity 15/26 (58 [37–77]) 17/26 (65 [44–83])
Negative predictive
value
15/18 (83 [59–96]) 17/21 (81 [58–95])
Positive predictive
value
59/67 (88 [78–95]) 61/70 (87 [77–94])
Per-vessel analysis
Diagnostic accuracy 335/396 (85 [81–88]) 351/396 (89 [85–92])*
Nondiagnostic rate 24/396 (6 [4–9]) 0/396 (0 [0–1])*
Sensitivity 89/106 (84 [76–90]) 92/106 (87 [79–93])
Speciﬁcity 247/290 (85 [81–89]) 259/290 (89 [85–93])*
Negative predictive
value
247/257 (96 [93–98]) 259/272 (95 [92–97])
Positive predictive
value
89/115 (77 [69–85]) 92/124 (74 [66–82])
Coronary Revascularization as the Reference Standard
Per-patient analysis
Diagnostic accuracy 54/91 (59 [49–70]) 58/91 (64 [53–74])
Nondiagnostic rate 6/91 (7 [3–14]) 0/91 (0 [0–4])*
Sensitivity 39/43 (91 [78–97]) 40/43 (93 [81–99])
Speciﬁcity 15/48 (31 [19–46]) 18/48 (38 [24–53])
Negative predictive
value
15/18 (83 [59–96]) 18/21 (86 [64–97])
Positive predictive
value
39/67 (58 [46–70]) 40/70 (57 [45–69])
Per-vessel analysis
Diagnostic accuracy 289/396 (73 [68–77]) 303/396 (77 [72–81])*
Nondiagnostic rate 24/396 (6 [4–9]) 0/396 (0 [0–1])*
Sensitivity 38/47 (81 [67–91]) 39/47 (83 [69–92])
Speciﬁcity 251/349 (72 [67–77]) 264/349 (76 [71–80])*
Negative
predictive value
251/257 (98 [95–99]) 264/272 (97 [94–99])
Positive
predictive value
38/115 (33 [25–42]) 39/124 (32 [23–40])
Values are n/N (% [95% CI]). Results are provided on the per-patient and -vessel level using the
following as the reference standard: 1) QCA for detection of 50% stenosis; and 2) subsequent
coronary revascularization of coronary stenosis (within 1 month). Note that both stenosis in native
vessel and ISR are considered in this table. The second reference standard was subsequent
coronary revascularization of any stenosis within 1 month after coronary angiography. Non-
diagnostic rate (p < 0.001) was signiﬁcantly improved with the combination of CTA and CTP on the
per-patient level of analysis. Also on the per-vessel level of analysis, diagnostic accuracy (p <
0.001) and nondiagnostic rate (p < 0.001) were signiﬁcantly improved with CTA/CTP versus CTA
alone. In 32 patients, an intermediate branch (segment 17) was present. Therefore, 396 vessels
are available for the per-vessel analysis including the 4 standard vessels (left main, left anterior
descending, left circumﬂex, and right coronary artery) in each of the 91 patients. Similar results
were found for coronary revascularization. The p values were obtained using the sign test. 95% CI
were estimated as described for unclustered data on the per-patient level (25) and clustered data
(stent level) as described (24). *Signiﬁcant difference (p < 0.05) in the comparison of CTA with
combined CTA/CTP.
Abbreviations as in Tables 1 and 2.
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1482(p ¼ 0.004) for CTA alone. CTP alone was insigniﬁcantly
inferior to CTA in ruling out ISR, with negative predictive
values of 90% and 95%, respectively (Table 2). In the per-
stent analysis, the sensitivity and speciﬁcity of CTA/CTP
were 78% and 90%, respectively, versus 56% (p ¼ 0.13) and
78% (p < 0.001) for CTA alone (Table 2). Online Tables 1to 4 provide detailed diagnostic performance results on all
levels of analysis.
Table 3 summarizes the data for detection of any CAD by
CTA and CTA/CTP. Diagnostic accuracy of combined
CTA/CTP (86%) in the per-patient analysis was higher than
that of CTA alone (81%; p ¼ 0.13), whereas the rate
of nondiagnostic examinations was signiﬁcantly reduced
(p < 0.001) (Table 3). In the per-vessel analysis, diagnostic
accuracy and nondiagnostic rate were also signiﬁcantly
improved by the addition of CTP (p< 0.001) (Table 3). The
per-patient sensitivity and speciﬁcity for combined CTA/
CTP were 94% and 65%, respectively, versus 91% (p¼ 0.48)
and 58% (p¼ 0.48) for CTA alone. In the per-vessel analysis,
the sensitivity and speciﬁcity of CTA/CTP were 87% and
89%, respectively, versus 84% (p¼ 0.13) and 85% (p< 0.001)
for CTA.
The correlation of stress imaging tests with CTA/CTP
for detection of any CAD and ISR is summarized in Online
Tables 5 and 6 and Online Tables 7 and 8, respectively,
indicating superiority of CTA/CTP. Figure 3 compares
CTA and CTP with CCA in a representative patient with
ISR. Stents nondiagnostic on CTA due to metal artifacts
(34 of 221, 15% of all stents) or motion (11 of 221, 5% of all
stents) mainly accounted for the limited diagnostic accuracy
of CTA. Coronary stent diameter signiﬁcantly inﬂuenced
interpretability on CTA but not on CTA/CTP, with more
nondiagnostic stents on CTA being located in stents with
diameters <3.0 mm (24 of 45, p < 0.05; after adjusting for
clustering effects: p ¼ 0.14) (Online Table 9).
The area under the ROC curve of CTA/CTP was
superior to that for CTA in identifying patients with ISR
(Fig. 4A). When subsequent revascularization was the
reference standard, the area under the ROC curve of CTA/
CTP was also superior (Fig. 4B). The ROC analysis results
on the per-stent and per-patient level did not differ.
Discussion
Our results indicate that combined coronary CTA and
myocardial CTP compares favorably with the diagnostic
performance of CTA alone in detecting coronary ISR and
CAD. Combined CTA/CTP had 87% accuracy for detec-
tion of ISR and 86% accuracy for CAD on the patient level,
which is the most relevant level and indicates robust diag-
nostic performance. The per-patient diagnostic accuracy of
CTA alone was only 71% for ISR and 81% for CAD with
nondiagnostic rates of 22% and 7%. An intention-to-
diagnose design using 3--2 tables was chosen because
this provides a realistic picture of the clinical potential of
diagnostic tests (11). If all nondiagnostic CTA were
considered positive, sensitivity for ISR detection on the per-
patient level would increase to 82% but the positive
predictive value would decrease to 42%. Importantly, the use
of CTP also improved the identiﬁcation of the need for
subsequent revascularization for ISR. However, our data also
conﬁrm the high negative predictive value of CTA, if
Figure 3 Coronary ISR in a 75-Year-Old Man With a 3-mm Stent in LAD
(A) Nondiagnostic CTA was performed because of artifacts related to metallic stent material (arrowhead), which were pronounced because of the small stent diameter and
precluded identiﬁcation of ISR. (B) CTP in the cardiac short axis identiﬁes stress-induced anteroseptal myocardial ischemia (arrows) resulting from 80% coronary ISR conﬁrmed
on CCA (arrow in C). (D) During the same invasive angiography, percutaneous coronary intervention with drug-eluting balloon was performed (arrow). LAD ¼ left anterior
descending coronary artery; other abbreviations as in Figure 1.
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1483evaluable, for coronary stent assessment (Table 2) and
detection of CAD (Table 3), which cannot be improved by
additional CTP. CTA/CTP detected 4 more of the 17 ISR
cases (sensitivity increase from 59% to 82%), but positive
predictive value decreased nonsigniﬁcantly from 77% to 61%
(Table 2). About one-half of patients had prior myocardial
infarctions and considering ﬁxed perfusion defects as positive
might have decreased speciﬁcity. Of 91 patients scanned by
CT in our study, 43 underwent any coronary revasculariza-
tion, for which CTA/CTP had 93% sensitivity (Table 3).
The need for 2 contrast agent injections of about 60 ml
and an effective radiation dose of about 7.9 mSv for
CTA/CTP argue against its routine clinical use. Neverthe-
less, the radiation dose of CTA/CTP was signiﬁcantly
smaller than that for CCA. The rather high dose for the
diagnostic portion of CCA may be explained by the high
prevalence and QCA-induced additional projections. As
shown in our study, the analysis of myocardial perfusion by
CT makes it possible to assess nondiagnostic stents on CTA,
an important point because metal- and motion-related arti-
facts often limit coronary stent analysis by CTA alone (4).
CTP primarily uses visual analysis supplemented by
assessment of absolute densities as well as transmural densitydifferences (16,20). In other studies, this approach has
provided incremental diagnostic power over CTA alone in
suspected or known CAD (30). Our intraindividual
comparison speciﬁcally addresses patients with coronary
stents using 320-row CT and demonstrates that additional
CTP facilitates the otherwise difﬁcult evaluation of coronary
stents but also of any CAD.
These ﬁndings must be interpreted in light of the perfor-
mance of other common noninvasive imaging modalities
such as myocardial single-photon emission CT, cardiac
magnetic resonance imaging, and stress echocardiography,
and CTP alone may not be accurate enough to reliably rule
out ISR, whereas CTA/CTP was signiﬁcantly more accurate
than stress tests were. Our results conﬁrm the increased
nondiagnostic rate of CTA in stents with small (<3 mm)
inner diameters (4). Importantly, CTP was not affected by
such challenging stent characteristics.
Study limitations. Our CT protocol included a coronary
artery calcium scan, which reduces the overall effective
radiation dose by limiting the anatomical coverage of the
subsequent CT scans (15). Calcium scans have shown to be
important predictors for coronary events in population-
based studies (31) but were not helpful for predicting ISR
Figure 4 Diagnostic Performance of CTA and Combined CTA/CTP
Receiver-operating characteristic (ROC) curve analysis of the diagnostic performance of CTA and CTA/CTP on the patient level. (A) The area under the ROC curve of CTA alone
for 50% ISR identiﬁed by quantitative coronary angiography (QCA) (0.76, 95% conﬁdence interval [CI]: 0.65 to 0.86) was signiﬁcantly smaller than that for CTA/CTP (0.90, 95%
CI: 0.81 to 0.99; p < 0.001). (B) The area under the ROC curve of CTA alone for predicting coronary stent revascularization (0.69, 95% CI: 0.57 to 0.82) was also signiﬁcantly
smaller than that for CTA/CTP (0.82, 95% CI: 0.69 to 0.95; p < 0.001). Abbreviations as in Figure 1.
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1484or any CAD in our study (data not shown). As it would be
done in clinical practice, CTP was always performed after
CTA. This may, however, have masked perfusion defects on
CTP. Also, beta-blockade treatment that is necessary to
reduce the heart rate for CTA (32) may have masked
ischemia. We did not perform other stress imaging tests in
all patients. Therefore, comparison of these tests with CT is
limited by partial veriﬁcation bias. Almost one-half of
patients screened had to be excluded, and of those eligible,
a considerable portion could not be included. Nevertheless,
the meticulous recording of this information is unique for
cardiac CT studies (32). Fractional ﬂow reserve measure-
ments, the functional reference standard for coronary lesions
(33), were only done at the discretion of the intervention-
alists. Instead, we analyzed the ability of CTA/CTP to
predict the need for subsequent coronary revascularization.
Whereas the importance of the prognostic information
provided by CTA has been established for coronary plaques
as well as obstructive lesions (34), it is not clear whether
CTP can add prognostic information.
Whether incorporating CT increases effectiveness, by
reducing multiple diagnostic testing in patients with coronary
stents, should be investigated in future studies. The expen-
diture on diagnostic imaging testing is increasing (35), and
every effort should be made to decrease its economic burden.
Whether CT can optimize cost-effectiveness compared with
traditional tests in patients with stents is an important
additional question (36).
Conclusions
The noninvasive detection of coronary stenosis in patients
with stents by CTA alone is limited, and the combination ofCTA and CTP has the potential to improve diagnostic
performance by adding functional information that may also
be relevant to the decision whether or not to perform
revascularization in symptomatic patients. Thus, further
studies are warranted to precisely deﬁne the role of CTA and
CTP as a means of positively altering outcomes in patients
with angina pectoris after coronary stent placement.
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